Synthesis and Cytostatic Activity of 4-Substituted Derivatives of Isoxazolyltriazenes

• Autorzy: Wagner E. , Opolski A. , Wietrzyk J.
• Języki publikacji: EN

Abstrakty

EN

4-(3,3-Alkyltriazeno)-5-benzoylisoxazole-3-carboxamides hydrochloride 6a-h and 7- benzoyl-3,4-dihydroisoxazolo[4,3-d]-[1,2,3]-triazyne-4-one 10 have been synthesized from 4-diazo-5-benzoylisoxazole-3-carboxamide chloride 5. Some from the triazenes were examined for cytostatic activity in comparison with Dacarbazine.

Słowa kluczowe

EN

triazenes; isoxazol[4,3-d]-v-triazyne; 4-dialkylamino isoxazoles

• Wydawca: Polskie Towarzystwo Chemiczne
• Czasopismo: Polish Journal of Chemistry
• Rocznik: 2003
• Tom: Vol. 77 / nr 8
• Strony: 1001--1006
• Opis fizyczny: Bibliogr. 23 poz., rys.

Twórcy

autor

Wagner E.

• Department of Drugs Technology, Wrocław Medical University, Pl. Nankiera 1, 50-140 Wrocław, Poland

autor

Opolski A.

• Department of Tumor Immunology, Institute of Immunology and Experimental Therapy, P.A.N., R. Weigla 12, 53-114 Wrocław, Poland

autor

Wietrzyk J.

• Department of Tumor Immunology, Institute of Immunology and Experimental Therapy, P.A.N., R. Weigla 12, 53-114 Wrocław, Poland

Bibliografia

• 1. Saunders K.H., The Aromatic Diazo Compounds, 2nd ed. Longmans, Green and Co., NY 1949, pp. 157.
• 2. Shealy Y.F., J. Pharm. Sei., 59, 1533 (1970).
• 3. Kimball D.B. and Haley M.M., Angew. Chem. Int. Ed., 41, 3338 (2002).
• 4. Connors T.A., Goddard P.M., Merai K., Ross W.C.J. and Wilman D.E.V., Biochem. Pharmacol., 25,241 (1976).
• 5. Hickman J.A., Biochimie, 60, 997 (1978).
• 6. Simmonds R.J., Mallawaarachichi W., Mallawaarachichi P.M. and Parry D.E., J. Chem. Soc. Perkin Trans, 2, 1399 (1993).
• 7. Moore J.S., Weinstein E.J. and Wu Z., Tetrahedron Lett., 32, 2465 (1991).
• 8. Preussman R., von Hodenberg A. and Hengy H., Biochem. Pharmac., 18, 1 (1969).
• 9. Smith RH., Jr., Waldkowski B.D., Herling J.A., Pfaltzgraff T.D., Taylor J.E., Thomson E.J., Pruski B., Klose J.R. and Micheida C.J., J. Org. Chem., 57, 6648 (1992).
• 10. Smith RH., Jr., Scudiero A.F. and Micheida C.J., J. Med. Chem., 40, 1886 (1997).
• 11. Carter S.K. and Friedman M.A., Eur. J. Cancer, 8, 85 (1972).
• 12. van Heyningen E., J. Am. Chem. Soc., 77, 6562 (1955).
• 13. Jollimore J.V., Vaughan K. and Hooper D.L., J. Org. Chem., 61, 210 (1996).
• 14. Shealy Y.F., Struck R.F., Holum L.B. and Montgomery J.A., J. Org. Chem., 26, 2396 (1961).
• 15. Jean-Claude B.J. and Just G., J Chem. Soc. Perkin Trans., 1, 2525 (1991).
• 16. Jean-Claude B.J. and Just G., Heterocycles, 48, 1347 (1998).
• 17. LeBIanc R.J. and Vaughan K., Can. J. Chem., 50, 2544 (1972).
• 18. Biesele J.J., Cancer, 5, 787 (1952).
• 19. Stevens M.F.G., Phillip K.S., Rathbone D.L., O’Shea D.M., Queener S.F., Schwalbe C.H. and Lambert P.A., J. Med. Chem., 40, 1886 (1997).
• 20. Ryng S., Malinka W. and Duś D, II Farmaco, 52, 105 (1997).
• 21. Zhu Z. and Moore J.S., J. Org. Chem., 65, 116 (2000).
• 22. Bratton A.C. and Marshall E.K., Jr., J. Biol. Chem., 128, 537 (1939).
• 23. Gewald K., Bellmann P. and Jänsh H.J., Liebigs Ann. Chem., 1623(1980).